Keratoacanthoma: Symptoms, Causes, and Treatment

Overview

Keratoacanthoma (KA) is a common, rapidly growing skin tumor that often appears on sun-exposed areas like the face, arms, and hands. While it resembles squamous cell carcinoma (a type of skin cancer), KA is generally considered a benign (non-cancerous) growth. However, it can be locally destructive if left untreated.

Who it affects: KA primarily affects adults over 50, though it can occur at any age. Men are more commonly affected than women. People with fair skin, a history of significant sun exposure, or weakened immune systems are at higher risk.

Prevalence: Keratoacanthomas account for about 3-5% of all skin tumors. They are more common in regions with high sun exposure, such as Australia and the southern United States.

Symptoms

Keratoacanthomas typically develop quickly, often growing to their full size within a few weeks. Key symptoms include:

• Rapidly growing bump: A firm, dome-shaped nodule that may reach 1-2 cm in diameter within weeks.
• Central crater: The growth often has a central depression filled with a keratin plug (a hard, waxy material).
• Color: The lesion may be skin-colored, pink, or reddish.
• Location: Commonly found on sun-exposed areas like the face (especially the nose and lips), forearms, and hands.
• Pain or itching: Some people experience mild discomfort or itching at the site.
• Spontaneous regression: In some cases, KA may shrink or disappear on its own after a few months, though this is unpredictable.

If you notice a rapidly growing skin lesion, especially with a central crater, consult a healthcare provider for evaluation.

Causes and Risk Factors

The exact cause of keratoacanthoma is unknown, but several factors are believed to contribute:

Causes:

• Sun exposure: Prolonged exposure to ultraviolet (UV) radiation is a major risk factor.
• Genetic mutations: Changes in genes like TP53 and HRAS may play a role.
• Skin injury: Trauma, burns, or surgical scars can trigger KA development.
• Viral infections: Some studies suggest a link to human papillomavirus (HPV).

Risk Factors:

• Fair skin and light hair/eyes.
• History of excessive sun exposure or tanning bed use.
• Older age (especially over 50).
• Weakened immune system (e.g., organ transplant recipients, HIV/AIDS).
• Exposure to certain chemicals (e.g., tar, pitch).
• Genetic syndromes like Muir-Torre syndrome or Ferguson-Smith syndrome.

Diagnosis

Diagnosing keratoacanthoma involves a combination of clinical examination and diagnostic tests:

Clinical Examination:

A dermatologist will examine the lesion for characteristic features like rapid growth, central crater, and keratin plug.

Diagnostic Tests:

• Skin biopsy: A small sample of the lesion is removed and examined under a microscope to confirm the diagnosis and rule out squamous cell carcinoma.
• Dermoscopy: A non-invasive tool that magnifies the skin to assess patterns and structures.
• Imaging (rarely): In cases of large or aggressive lesions, imaging like ultrasound or MRI may be used to assess depth and involvement of underlying tissues.

Early diagnosis is crucial to distinguish KA from malignant growths and initiate appropriate treatment.

Treatment Options

Treatment depends on the size, location, and aggressiveness of the lesion. Options include:

Surgical Removal:

• Excisional surgery: The entire lesion is cut out, often with a margin of healthy tissue. This is the most common treatment.
• Mohs surgery: A precise technique where layers of skin are removed and examined until no abnormal cells remain. Ideal for large or recurrent lesions.

Non-Surgical Treatments:

• Cryotherapy: Freezing the lesion with liquid nitrogen. Best for small, early-stage KAs.
• Topical medications: Imiquimod or 5-fluorouracil (5-FU) creams may be used for superficial lesions.
• Intralesional injections: Corticosteroids or chemotherapy drugs (e.g., methotrexate) injected directly into the lesion.
• Radiation therapy: Rarely used for aggressive or recurrent cases.

Lifestyle and Home Care:

• Avoid picking or scratching the lesion to prevent infection or scarring.
• Use sunscreen (SPF 30+) and protective clothing to prevent new lesions.
• Follow up with your dermatologist for monitoring.

Living with Keratoacanthoma

If you’ve been diagnosed with KA, follow these tips to manage your condition:

• Monitor your skin: Check for new or changing lesions regularly. Use a mirror or ask a family member to help with hard-to-see areas.
• Protect your skin: Wear broad-spectrum sunscreen daily, even on cloudy days. Reapply every 2 hours when outdoors.
• Wear protective clothing: Hats, long sleeves, and UV-blocking sunglasses can reduce sun exposure.
• Avoid tanning beds: Artificial UV radiation increases the risk of new lesions.
• Stay hydrated and eat a balanced diet: Healthy skin is less prone to abnormalities.
• Attend follow-up appointments: Regular check-ups help detect recurrences early.

Prevention

While not all cases of keratoacanthoma can be prevented, you can reduce your risk by:

• Limiting sun exposure: Avoid peak sun hours (10 AM–4 PM) and seek shade when outdoors.
• Using sunscreen: Apply SPF 30+ sunscreen to all exposed skin, even in winter.
• Wearing protective clothing: Opt for tightly woven fabrics and wide-brimmed hats.
• Avoiding tanning beds: Artificial UV radiation is just as harmful as sunlight.
• Protecting skin from injury: Cuts, burns, or other trauma can trigger KA development.
• Checking your skin regularly: Early detection leads to easier treatment.

Complications

If left untreated, keratoacanthoma can lead to:

• Local destruction: The lesion may grow deeper into the skin, damaging surrounding tissue.
• Scarring: Large or untreated KAs can leave significant scars, especially on the face.
• Infection: Open sores or ulcers can become infected.
• Misdiagnosis: KA can be mistaken for squamous cell carcinoma, leading to unnecessary anxiety or delayed treatment.
• Recurrence: Some lesions may return after treatment, especially if not fully removed.

Prompt treatment reduces the risk of complications and improves cosmetic outcomes.

When to Seek Emergency Care

References

• Mayo Clinic. (2022). Keratoacanthoma.
• American Academy of Dermatology. (2021). Keratoacanthoma: Diagnosis and Treatment.
• National Institutes of Health (NIH). (2020). Genetics of Keratoacanthoma.
• Cleveland Clinic. (2021). Keratoacanthoma: Management and Outlook.